Berberine improves liver injury following renal ischemia reperfusion in rats

Iranian Journal of Science and Technology, Transaction A: Science

Volumn 39, Issue A1, 2015, Pages 17-23

  Gholampour, F ^a   Karimifard, F ^a   Owji, S M ^b  

^a SHIRAZ UNIVERSITY   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Alanine aminotransferase; Aspartate aminotransferase; Berberine; Lactate dehydrogenase; Liver; Renal ischaemia reperfusion

Indexed keywords

EID: 84927564253     PISSN: 10286276     EISSN: 23641819     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Akarasereenont, P., Bakhle, Y. S, Thiemermann, C., & Vane, J. R. (1995). Cytokinemediated induction of cyclo oxygenase-2 by activation of tyrosine kinase in bovine endothelial cells stimulated by bacterial lipopolysaccharide. British Journal of Pharmacology, 115, 401–408.
2. Beyaert, R., Fiers, W. (1998). Tumor necrosis factor and lymphotoxin. In A. R. Mire-Sluis, R. Thorpe (Ed), Cytokines (pp. 335–359). San Diego: Academic Press.
3. Bhalodia, Y. S., Sheth, N. R., Vaghasiya, J. D., & Jivani, N. P. (2010). Hyperlipidemia enhanced oxidative stress and inflammatory response evoked by renal ischemia/reperfusion injury. International Journal of Pharmacology, 6, 25–30.
4. Canbek, M., Ustünemr M. C., Kabay, S., Uysal, O., Ozden, H., Bayramoğlu, G., & et al. (2011). The effect of gallic acid on kidney and liver after experimental renal ischemia/reperfusion injury in the rats. African Journal of Pharmacy and Pharmacology, 5(8), 1027–1033.
5. Cuzzocrea, S., McDonald, M. C., Filipe, H. M., Costantino, G., Mazzon, E., & et al. (2000). Effects of tempol, a membrane-permeable radical scavenger, in a rodent model of carrageenan-induced pleurisy. European Journal of Pharmacology, 390, 209–22.
6. Jakovacb, H.,. (2011). Hepatoprotective activity of berberine is mediated by inhibition of TNF-, COX-2, and iNOS expression in CCl4-intoxicated mice. Toxicology, 28, 33–43.
7. Domitrovi´ c R., Jakovac, H., Milin, C., & Radoˇsevi´c- Staˇsi ´c, B. (2009). Dose- and time-dependent effects of luteolin on carbon tetrachloride-induced hepatotoxicity in mice. Experimental and Toxicologic Pathology, 61, 581– 589.
8. Dubois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., Van De Putte, L. B., & et al. (1998) Cyclooxygenase in biology and disease. The FASEB Journal, 12, 1063–1073.
9. Erdogan, H., Fadillioglu, E., Yagmurca, M., Ucar, M., & Irmak, M. K. (2006). Protein oxidation and lipid peroxidation after renal ischemia-reperfusion injury: protective effects of erdosteine and N-acetylcysteine. Urological Research, 34, 41–46.
10. Giannini, E. G., Testa, R., & Savarino, V. (2005). Liver enzyme alteration: a guide for clinicians. Canadian Medical Association Journal, 172(3), 367–379.
11. González-Amaro, R., García-Monzón, C., García-Buey, L., Moreno-Otero, R., Alonso, J. L., &, et al. (1994). Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. Journal of Experimental Medicine, 179, 841–848.
12. Grimble, R. F. (1994). Nutritional antioxidants and the modulation of inflammation: theory and practice. New Horizons, 2, 175–185.
13. Hsiang, C. Y., Wu, S. L., Cheng, S. E., & Ho, T. Y, (2005). Acetaldehyde-induced interleukin-1beta and tumor necrosis factor-alpha production is inhibited by berberine through nuclear factor-kappaB signaling pathway in HepG2 cells. Journal of Biomedical Science, 12, 791–801.
14. Imanshahidi, M., & Hosseinzadeh, H. (2008). Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytotherapy Research, 22, 999–1012.
15. Iwasa, K., Kamigauchi, M., Uek, M., & Taniguchi, M. (1996). Antibacterial activity and structure-activity relationships of berberine analogs. European Journal of Medicinal Chemistry. 31, 469–478.
16. Jeong, H. W., Hsu, K. C., Lee, J. W., & et al. (2009). Berberine suppresses proinflammatory responses through AMPK activation in macrophages. American Journal of Physiology - Endocrinology and Metabolism, 296, E955– E964.
17. Kadkhodaee, M., Golab, F., Zahmatkesh, M., Ghaznavi, R., Hedayati, M., Arab, H. A., & et al. (2009). Effects of different periods of renal ischemia on liver as a remote organ. World Journal of Gastroenterology, 15(9), 1113– 1118.
18. Kelly, K. J. (2003). Distant effects of experimental renal ischemia/reperfusion injury. Journal of the American Society of Nephrology, 14, 1549–1558.
19. Kelly, K. J., & Molitoris, B. A. (2000). Acute renal failure in the new millennium: time to consider combination therapy. Seminars in Nephrology, 20, 4–19.
20. Kettmann, V., Kosfálová, D., Jantová, S., Cernáková, M., & Drímal, J. (2004). In vitro cytotoxicity of berberine against HeLa and L1210 cancer cell lines. Pharmazie, 59, 548–551.
21. Kielar, M. L., John, R., Bennett, M., Richardson, J. A., Shelton, J.M., Shelton, J.M., & et al. (2005).Maladaptive role of IL-6 in ischemic acute renal failure. Journal of the American Society of Nephrology, 16, 3315–3325.
22. Kuo, C. L., Chi, C.W., & Liu, T. Y. (2004). The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Letters, 203, 127–137.
23. Leiro, J., Alvarez, E., Arranz, J. A., Laguna, R., Uriarte, E., & Orallo, F. (2004). Effects of cis-resveratrol on inflammatory murine macrophages: antioxidant activity and down-regulation of inflammatory genes. Journal of Leukocyte Biology, 75(6), 1156–65.
24. Lin, Y., Choksi, S., Shen, H. M., Yang, Q. F., Hur, G. M., Kim, Y. S., & et al. (2004). Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein- mediated cellular reactive oxygen species accumulation. Journal of Biological Chemistry, 279, 10822–8.
25. Nussler, A. K., & Billia, T. R. (1993). Inflammation, immunoregulation, and inducible nitric oxide synthase. Journal of Leukocyte Biology, 54, 171–178.
26. Park, S. W., Chen, S. W. C., Kim, M., Brown, K. M., Kolls, J. K., D'Agati, V. D., & et al. (2011.) Cytokines induce small intestine and liver injury after renal ischemia or nephrectomy. Laboratory Investigation, 91(1), 63–84.
27. Pattanayak, S., Nayak, S. S., Panda, D. P., Dinda, S. C., Slende, U., & Jadav, A. (2011). Hepatoprotective activity of crude flavonoids extract of Cajanus scarabaeoides (L) in paracetamol intoxicated albino rats. Asian Journal of Pharmaceutical and Biological Research, 1, 22–27.
28. Pawliczak, R. (2003). The role of radical oxygen species in airway inflammation. Polski Merkuriusz Lekarski, 14, 493–6.
29. Plaa, G. L., & Hewitt, W. R. (1989). Detection and evaluation of chemically induced liver injury. In A. W. Hayes (Ed.), Principles and Methods of Toxicology (pp. 399–628). New York: Raven Press.
30. Racková, L., Májeková, M., Kost'álová, D., & Stefek, M. (2003). Antiradical and antioxidant activities of alkaloids isolated from Mahonia aquifoliu. Structural aspects. Bioorganic & Medicinal Chemistry, 12, 4709–4715.
31. Ramesh, G., & Reeves, W. B. (2004). Inflammatory cytokines in acute renal failure. Kidney International, 91, S56–S61.
32. Ravikumar, V., Shivashangari, K. S., & Devaki, T. (2005). Hepatoprotective activity of Tridax procumbens against D-galactosamine/lipopolysaccharide-induced hepatitis in rats. Journal of Ethnopharmacology, 101, 55–60.
33. Renz, A., Berdel, W. E., Kreuter, M., Belka, C., Schulze- Osthoff, K., & Los, M. (2001). Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo. Blood, 98, 1542–8.
34. Rouschop, K. M. A., Roelofs, J. J. T. A., Claessen, N., Martins, P.d C., Zwaginga, J. J., Pals, S. T., & et al. (2005). Protection against renal ischemia reperfusion injury by CD44 disruption. Journal of the American Society of Nephrology, 16, 2034–2043.
35. Simeonova, P. P., Gallucci R. M., Hulderman T., Wilson, R., Kommineni, C., Rao, M., & et al. (2001). The role of tumor necrosis factor-alpha in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride. Toxicology and Applied Pharmacology, 177, 112–120.
36. Stermitz, F. R., Lorenz, P., Tawara, J. N., Zenewicz L. A., & Lewis, K. (2000). Synergy in a medicinal plant: Antimicrobial action of berberine potentiated by 5-methoxyhydrocarpin, a multidrug pump inhibitor. Proceedings of the National Academy of Sciences of the United States of America, 97, 1433–1437.
37. Sural, S., Sharma, R. K., Gupta, A., Sharma, A. P., & Gulati, S. (2000). Acute renal failure associated with liver disease in India: etiology and outcome. Renal Failure, 22, 623– 634.
38. Takeda, M., Shirato, I., Kobayashi, M., & Endou, H. (1999). Hydrogen peroxide induces necrosis, apoptosis, oncosis and apoptotic oncosis of mouse terminal proximal straight tubule cells. Nephron, 81, 234–8.
39. Uyanoglu, M., Canbek, M., Ceyhan, E., Senturk, H., Bayramoglu, G., Gunduz, O., & et al. (2011). Preventing organ injury with carvacrol after renal ischemia/reperfusion. Journal of Medicinal Plants Research, 5(1), 72–80.
40. Vaghasiya, J. D., Sheth, N. R., Yagnik, S. B. & Jivani, N. P. (2010). Exagegerated liver injury induced by renal ischemia reperfusion in diabetes: effect of exentide. Saudi Journal of Gastroenterology, 16(3),174–180.
41. Wang, B., Bai, M., Bai, Y., & Li, Q. (2010). Liver injury following renal ischemia reperfusion in rats. Transplantation Proceedings, 42, 3422–3426.
42. Weight, S. C., Bell, P. R., & Nicholson, M. L. (1996). Renal ischaemia-reperfusion injury. British Journal of Surgery, 83, 162–170.
43. Yildirim, A., Gumus, M., Dalga, S., Sahin, Y. N., & Akcay, F. (2003). Dehydroepiandrosterone improves hepatic antioxidant systems after renal ischemia-reperfusion injury in rabbits. Annals of Clinical & Laboratory Science, 33, 459–464.